Global Health Ltd
Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.[1]
- Market Cap ₹ 31,968 Cr.
- Current Price ₹ 1,189
- High / Low ₹ 1,456 / 955
- Stock P/E 64.4
- Book Value ₹ 149
- Dividend Yield 0.04 %
- ROCE 17.1 %
- ROE 13.2 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 54.3% CAGR over last 5 years
Cons
- Stock is trading at 7.96 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE 500 BSE Healthcare Nifty 500 Nifty500 Shariah BSE SmallCap Select Index
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1,277 | 1,343 | 1,441 | 1,472 | 1,227 | 1,765 | 1,974 | 2,975 | 3,204 | 3,709 | |
| 1,158 | 1,218 | 1,297 | 1,253 | 1,054 | 1,384 | 1,551 | 2,222 | 2,432 | 2,954 | |
| Operating Profit | 119 | 125 | 144 | 219 | 173 | 381 | 423 | 753 | 772 | 755 |
| OPM % | 9% | 9% | 10% | 15% | 14% | 22% | 21% | 25% | 24% | 20% |
| 67 | 49 | 64 | 43 | 28 | 35 | 47 | 91 | 41 | 106 | |
| Interest | 19 | 24 | 21 | 33 | 29 | 33 | 32 | 51 | 41 | 41 |
| Depreciation | 77 | 86 | 91 | 99 | 88 | 87 | 86 | 134 | 150 | 171 |
| Profit before tax | 89 | 64 | 97 | 131 | 84 | 296 | 352 | 659 | 623 | 650 |
| Tax % | 39% | 42% | 35% | 22% | 32% | 26% | 25% | 26% | 26% | 24% |
| 54 | 37 | 63 | 103 | 57 | 219 | 263 | 486 | 462 | 496 | |
| EPS in Rs | 11.21 | 7.70 | 12.81 | 20.82 | 11.55 | 8.64 | 9.82 | 18.11 | 17.18 | 18.46 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 25% |
| 3 Years: | 23% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 54% |
| 3 Years: | 23% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 27% |
| 1 Year: | 0% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 15% |
| 3 Years: | 15% |
| Last Year: | 13% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 48 | 48 | 49 | 49 | 50 | 51 | 54 | 54 | 54 | 54 |
| Reserves | 1,070 | 1,141 | 1,230 | 1,341 | 1,434 | 1,689 | 2,435 | 2,983 | 3,444 | 3,959 |
| 215 | 201 | 168 | 51 | 228 | 308 | 288 | 424 | 337 | 233 | |
| 303 | 318 | 310 | 517 | 291 | 314 | 402 | 523 | 606 | 1,105 | |
| Total Liabilities | 1,637 | 1,709 | 1,758 | 1,958 | 2,002 | 2,361 | 3,179 | 3,984 | 4,441 | 5,351 |
| 966 | 1,162 | 869 | 929 | 851 | 827 | 810 | 1,645 | 1,861 | 2,903 | |
| CWIP | 8 | 7 | 5 | 3 | 4 | 6 | 75 | 280 | 458 | 120 |
| Investments | 21 | 0 | 356 | 500 | 626 | 734 | 765 | 362 | 366 | 389 |
| 642 | 540 | 528 | 525 | 521 | 794 | 1,529 | 1,698 | 1,757 | 1,939 | |
| Total Assets | 1,637 | 1,709 | 1,758 | 1,958 | 2,002 | 2,361 | 3,179 | 3,984 | 4,441 | 5,351 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 124 | 152 | 193 | 201 | 235 | 431 | 559 | 528 | 573 | ||
| -112 | -104 | -45 | -250 | -313 | -257 | -519 | -638 | -931 | ||
| -6 | -49 | -56 | -37 | 98 | 404 | -379 | -94 | 264 | ||
| Net Cash Flow | 6 | -1 | 92 | -86 | 20 | 577 | -339 | -205 | -94 | |
| Free Cash Flow | 34 | 123 | 176 | 178 | 171 | 315 | 335 | 102 | -102 | |
| CFO/OP | 153% | 153% | 114% | 125% | 86% | 126% | 97% | 89% | 90% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 31 | 41 | 42 | 37 | 39 | 36 | 32 | 26 | 33 | 38 |
| Inventory Days | 36 | 26 | 26 | 37 | 39 | 33 | 34 | 29 | 24 | 23 |
| Days Payable | 132 | 124 | 142 | 135 | 134 | 84 | 113 | 84 | 81 | 93 |
| Cash Conversion Cycle | -66 | -56 | -74 | -61 | -56 | -16 | -48 | -29 | -24 | -32 |
| Working Capital Days | -31 | -16 | -7 | -11 | -20 | -6 | -27 | -24 | -14 | -4 |
| ROCE % | 6% | 8% | 11% | 7% | 17% | 16% | 23% | 20% | 17% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| ALOS (Average Length of Stay) Days |
|
|||||
| ARPOB (Average Revenue Per Occupied Bed) INR |
||||||
| Census Beds Count |
||||||
| In-Patient Volumes (IPD) Admissions |
||||||
| Installed Beds Count |
||||||
| Occupancy Rate Percentage |
||||||
| Out-Patient Volumes (OPD) Visits |
||||||
Extracted by Screener AI
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
23 May - FY26 secretarial compliance report filed; 6-day gap noted in financial results submission.
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
23 May - Intimation under Regulation 30 of Listing regulations regarding Allotment of Shares.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
22 May - Intimation under SEBI Listing Regulations regarding Schedule of Analyst Meet.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
22 May - Global Health to meet ICICI Prudential AMC on May 27 and IIFL Capital Asset Management on May 28, 2026.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
20 May - Announcement under Regulation 30 of Listing Regulations 2015 for Earning Conference call Transcript.
Annual reports
Concalls
-
May 2026Transcript PPT REC
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
May 2025TranscriptAI SummaryPPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptAI SummaryPPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Dec 2022TranscriptAI SummaryPPT
Hospital Count[1]
Global Health operates 6 hospitals under the "Medanta" brand in Gurugram, Indore, Ranchi, Lucknow, Patna and Noida. Spanning an area of 5.6 million sq. ft., they have 3,435 installed beds as on Sep 30, 2025. They provide healthcare services in over 30 medical specialties and engage 2,000+ doctors led by highly experienced department heads.